store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MPP+ iodide 是一种 5-羟色胺转运体的高亲和力底物,也是一种神经毒素 MPTP 的有毒代谢物,通过选择性破坏黑质多巴胺能神经元,在动物模型中引起帕金森病症状。它被多巴胺转运体吸收进入多巴胺能神经元,通过影响呼吸链复合体 I 对线粒体发挥神经毒性作用。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 318 | 现货 | ||
10 mg | ¥ 459 | 现货 | ||
25 mg | ¥ 755 | 现货 | ||
50 mg | ¥ 1,120 | 现货 | ||
100 mg | ¥ 1,660 | 现货 | ||
200 mg | ¥ 2,470 | 现货 | ||
500 mg | ¥ 3,970 | 现货 | ||
1 g | ¥ 5,830 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 795 | 现货 |
产品描述 | MPP+ iodide, the metabolite of a neurotoxin MPTP, causes symptom of Parkinson's disease (PD) in animal models by selectively destroying dopaminergic neurons in substantia nigra. MPP+ induces dopamine transporter (DAT) externalization in dopaminergic (DA) neurons, but internalization of serotonin transporter (SERT) in serotonergic (5-HT) neurons. MPP+ induces autophagic cell death in SH-SY5Y cells. |
体外活性 | SH-SY5Y cells were treated with MPP+, mimicking the progress of dopaminergic neurons loss in PD. MPP+ (1-3 mM; 24 hours) remarkably decreases the viability of cells in both dose-dependent (1, 2, 3 mM for 24 h) and time dependent (1 mM) manner.[1]. MPP+ also inhibits the activity of nicotinamide adenosine dinucleotide (NADH)-linked respiration in mitochondrial preparations and impairs aerobic glycolysis, leading to the present belief that the inhibition of NADH-linked cell respiration may constitute the final molecular mechanism of MPP+ neurotoxicity[3]. |
分子量 | 297.13 |
分子式 | C12H12IN |
CAS No. | 36913-39-0 |
store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 100 mg/mL (336.54 mM), Sonication is recommended.
DMSO: 62.5 mg/mL (210.34 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O / DMSO | 1 mM | 3.3655 mL | 16.8277 mL | 33.6553 mL | 84.1383 mL |
5 mM | 0.6731 mL | 3.3655 mL | 6.7311 mL | 16.8277 mL | |
10 mM | 0.3366 mL | 1.6828 mL | 3.3655 mL | 8.4138 mL | |
20 mM | 0.1683 mL | 0.8414 mL | 1.6828 mL | 4.2069 mL | |
50 mM | 0.0673 mL | 0.3366 mL | 0.6731 mL | 1.6828 mL | |
100 mM | 0.0337 mL | 0.1683 mL | 0.3366 mL | 0.8414 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
MPP+ iodide 36913-39-0 Autophagy Metabolism Mitochondrial Metabolism MPP+ dopaminergic neurons respiratory chain Inhibitor inhibit neurotoxic MPP+ Iodide complex inhibitor